pyridoxal isonicotinoyl hydrazone
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 1989 (NCT00000588)
Timeline
1980s
- Jan 1, 1989
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 4-pyridinecarboxylic acid, ((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinyl)methylene)hydrazide
- ferric pyridoxal isonicotinoyl hydrazone
- pyridoxal isonicotinoyl hydrazone
- pyridoxal isonicotinoyl hydrazone
- pyridoxal isonicotinoyl hydrazone
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00000588 | Phase 2 | Jun 1, 1989 | Case Western Reserve University, National Heart, Lung, and Blood Institute (NHLBI) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Case Western Reserve University | Academic/Hospital | 1 | 1 | 1 | 1989 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 1989 |
2 organizations
Page 1 / 1